Analysis | Metabolite Name | Measured Value | Units | Treatment | Source |
---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | Pyridoxamine | 120206.0027 | Area | n/a | n/a |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 160316.0092 | Area | n/a | n/a |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 164027.197 | Area | n/a | n/a |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 169031.7975 | Area | n/a | n/a |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 175570.8731 | Area | n/a | n/a |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 278978.1142 | Area | n/a | n/a |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 285910.5661 | Area | n/a | n/a |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 370187.848 | Area | n/a | n/a |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 24796964.84 | Area | HS14 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 36787618.06 | Area | LS | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 37699273.67 | Area | HS21 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 38159846.5 | Area | HS14 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 42815063.45 | Area | HS14 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 44950219.84 | Area | HS21 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 47325433.23 | Area | HS14 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 47678045.09 | Area | HS21 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 48042848.09 | Area | HS14 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 48087302.25 | Area | HS7 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 50969374.42 | Area | HS14 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 51132380.22 | Area | HS7 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 52530058.86 | Area | HS21 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 52906944.85 | Area | LS | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 53551907.26 | Area | LS | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 53638776.61 | Area | HS7 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 53949156.36 | Area | LS | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 54049652.18 | Area | HS7 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 54050418.84 | Area | LS | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 55403718.25 | Area | HS21 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 56919991.3 | Area | HS7 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 57106873.4 | Area | HS14 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 57278062.74 | Area | HS14 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 57907200.09 | Area | HS21 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 58252666.23 | Area | Plasma Pool | Plasma Pool |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 59236427.52 | Area | HS14 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 59677403.06 | Area | HS21 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 62392019.63 | Area | HS7 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 63460087.71 | Area | HS7 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 63514606.55 | Area | HS7 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 63709187.52 | Area | HS14 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 64866585.47 | Area | HS7 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 65411615.47 | Area | HS7 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 65574551.47 | Area | HS21 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 67382697.26 | Area | HS7 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 67633678.13 | Area | LS | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 67774092.86 | Area | Plasma Pool | Plasma Pool |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 67941020.45 | Area | HS14 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 67976916.4 | Area | LS | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 69383463.3 | Area | LS | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 70962458.19 | Area | HS7 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 71856669.63 | Area | HS14 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 73121890.11 | Area | HS21 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 73145506.21 | Area | HS7 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 73688671.35 | Area | HS21 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 75968945.59 | Area | HS21 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 78334437.07 | Area | HS21 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 78776176.96 | Area | HS21 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 79314956.21 | Area | HS14 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 80680101.66 | Area | HS21 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 82585874.13 | Area | Plasma Pool | Plasma Pool |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 82751983.41 | Area | Plasma Pool | Plasma Pool |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 83509276.25 | Area | HS14 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 83779573.83 | Area | HS7 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 83863767.82 | Area | HS14 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 86297646.76 | Area | HS14 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 87249462.19 | Area | HS7 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 87618269.18 | Area | LS | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 88423167.84 | Area | LS | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 89302225.58 | Area | Plasma Pool | Plasma Pool |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 90322855.5 | Area | LS | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 91217574.66 | Area | Plasma Pool | Plasma Pool |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 97140078.47 | Area | HS14 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 98399856.83 | Area | HS21 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 99420368.9 | Area | HS21 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 99543074.65 | Area | HS21 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 101274873.3 | Area | Plasma Pool | Plasma Pool |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 102278139.5 | Area | LS | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 103400034 | Area | HS21 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 104334281.7 | Area | HS14 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 104834292.5 | Area | HS21 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 105255525.3 | Area | HS21 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 106923198.2 | Area | HS7 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 107743180.5 | Area | HS14 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 108064916.1 | Area | HS7 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 108381547.2 | Area | LS | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 109886278.8 | Area | HS7 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 110995211.5 | Area | HS7 | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 111666474.4 | Area | LS | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 114012586.3 | Area | LS | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 115571754.2 | Area | HS7 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 116897940.4 | Area | HS14 | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 118587605.3 | Area | Plasma Pool | Plasma Pool |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 127078986.1 | Area | LS | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 130510043.6 | Area | LS | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 131703522.4 | Area | LS | Vein Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 151209194 | Area | LS | Artery Plasma |
Reversed phase POSITIVE ION MODE | Pyridoxamine | 162375666.8 | Area | LS | Artery Plasma |